[go: up one dir, main page]

PT73605B - Process for preparing treatment of brain injury due to gray matter edema with indanyloxybutric acids - Google Patents

Process for preparing treatment of brain injury due to gray matter edema with indanyloxybutric acids

Info

Publication number
PT73605B
PT73605B PT73605A PT7360581A PT73605B PT 73605 B PT73605 B PT 73605B PT 73605 A PT73605 A PT 73605A PT 7360581 A PT7360581 A PT 7360581A PT 73605 B PT73605 B PT 73605B
Authority
PT
Portugal
Prior art keywords
carbon atoms
gray matter
indanyloxybutric
acids
brain injury
Prior art date
Application number
PT73605A
Other languages
English (en)
Other versions
PT73605A (en
Inventor
Edward J Cragoe Jr
Otto W Woltersdorf Jr
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PT73605A publication Critical patent/PT73605A/pt
Publication of PT73605B publication Critical patent/PT73605B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT73605A 1980-09-02 1981-09-01 Process for preparing treatment of brain injury due to gray matter edema with indanyloxybutric acids PT73605B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18354680A 1980-09-02 1980-09-02

Publications (2)

Publication Number Publication Date
PT73605A PT73605A (en) 1981-10-01
PT73605B true PT73605B (en) 1983-09-01

Family

ID=22673265

Family Applications (1)

Application Number Title Priority Date Filing Date
PT73605A PT73605B (en) 1980-09-02 1981-09-01 Process for preparing treatment of brain injury due to gray matter edema with indanyloxybutric acids

Country Status (9)

Country Link
EP (1) EP0047011B1 (pt)
JP (1) JPS57145832A (pt)
AT (1) ATE13877T1 (pt)
DE (1) DE3171029D1 (pt)
DK (1) DK386581A (pt)
ES (1) ES8303278A1 (pt)
GR (1) GR75754B (pt)
IE (1) IE51535B1 (pt)
PT (1) PT73605B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61103850A (ja) * 1984-10-29 1986-05-22 Ono Pharmaceut Co Ltd 3−(インダン−5−イルオキシ(またはチオ))シクロペンタンカルボン酸誘導体、それらの製造方法及びそれらを有効成分として含有する治療剤
JPS6219552A (ja) 1985-07-19 1987-01-28 Ono Pharmaceut Co Ltd 3−〔(4−アロイル)フエノキシ(またはフエニルチオ)〕シクロペンタンカルボン酸誘導体、それらの製造方法及びそれらを有効成分として含有する脳浮腫治療剤
US12059403B2 (en) 2016-08-04 2024-08-13 University Of Iowa Research Foundation Use of SWELL1 inhibitors and modulators to treat type 2 diabetes and obesity
EP3979998A4 (en) * 2019-06-10 2023-07-19 Washington University Swell1-lrrc8 complex modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984465A (en) * 1972-10-13 1976-10-05 Merck & Co., Inc. 1-Oxo-2,2-disubstituted-5-indanyloxy(or thio)alkanoic acids
NL187854C (nl) * 1973-10-11 1992-02-03 Merck & Co Inc Werkwijze ter bereiding van farmaceutische preparaten met diuretische en saluretische werking, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte op plaats 2 gesubstitueerde 1-oxo-5-indanyloxy-(of -thio-)-alkaanzuren.
US4012524A (en) * 1973-10-12 1977-03-15 Merck & Co., Inc. [1-Hydroxy-5-indanyloxy (or thio)]-alkanoic acids

Also Published As

Publication number Publication date
DK386581A (da) 1982-03-03
GR75754B (pt) 1984-08-02
ATE13877T1 (de) 1985-07-15
ES505115A0 (es) 1982-12-16
IE51535B1 (en) 1987-01-07
EP0047011A1 (en) 1982-03-10
PT73605A (en) 1981-10-01
JPS57145832A (en) 1982-09-09
ES8303278A1 (es) 1983-02-16
DE3171029D1 (en) 1985-07-25
EP0047011B1 (en) 1985-06-19
IE811935L (en) 1982-03-02

Similar Documents

Publication Publication Date Title
GR3035587T3 (en) Thienobenzodiazepine derivatives for treatment of CNS disorders.
EP0138280A3 (en) Blood-pressure lowering piperazine derivatives
ES2000823A6 (es) Metodo para la produccion de compuestos analogos a la vitamina d
DE3370585D1 (en) Use of aminophenylacetic acid derivatives for the manufacture of an immunomodulating medical preparation
ES2057126T3 (es) Metodo de tratamiento de la caquexia y algunos nuevos compuestos para utilizar en este metodo.
TW230750B (pt)
HUT40101A (en) Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents
EP0285278A3 (en) Method of treating anxiety with tetrahydrobenzûc,d¨indole-6-carboxamides
IL87834A0 (en) Novel oxathiolanes
PT73605A (en) Process for preparing treatment of brain injury due to gray matter edema with indanyloxybutric acids
EP0150505A3 (en) 3-indolecarboxamide compounds
HU9202273D0 (en) Method for producing medical preparative applicable against disturbances of cerebral activity
MA20352A1 (fr) Procede de preparation de derives d'isoxasole
GB8925032D0 (en) Chemical compounds
DE3661311D1 (en) Novel guanidinomethylcyclohexancarboxylic acid compounds, processes for preparing them, and pharmaceutical compositions containing them
EP0368536A3 (en) Preparation of cycloorganotrisilazanes
TW232018B (pt)
HU9203052D0 (en) Method for treatment of hypertension
DE3175939D1 (en) Use of gamma-piperidino-butyrophenones for the preparation of medicaments for treating diarrhoea
FR2481697B1 (pt)
HU9302546D0 (en) Heteroarenyl-piperazine derivatives, method for producing them and medical preparatives containing said compounds
GB2014995A (en) (Cycloalkyl)-alkylbenzamides
DE69006038D1 (de) 1,3-Dioxolan-benzoesäure und Derivate davon.